University College Hospital (UCH)

2010 - 2012


Hugh Turvey, the ‘X-ray artist’ (www.x-rayartist.com), will work closely with the Department of Specialist Imaging at University College Hospital (UCH) to create works of art from dramatic new multi-sequence MRI scans of the prostate, used in the detection of small foci of prostate cancer. Hugh’s innovative artistic techniques, in combination with the world-leading imaging technology developed in UCH, will provide a challenging, accessible and visually arresting way in to this crucial subject. The goal of the project will be to stimulate discussion and debate about research into prostate cancer and the way in which it is currently managed as well as to develop a genuinely interdisciplinary model for artistic and scientific collaboration. It will also allow men to appreciate the impact of this research by exhibiting the artworks at targeted venues in London and around the country.

Rowland Illing: Rowland qualified as a doctor in 1998, gained Membership of the Royal College of Surgeons of England in 2001 before undertaking research into minimally invasive therapies for the treatment of cancer. This research, which led to a DM Thesis from Oxford University, required him to manage four clinical trials funded by £5M independently sourced venture capital. During this time he also secured a substantial grant from the BUPA Foundation. He was invited to join the Minimally Invasive Prostate Intervention (MIPI) Group based at UCH/UCL in 2005. A passion for using novel imaging techniques as a means of guiding therapy prompted him to re-train as a Radiologist, becoming a Fellow of the Royal College of Radiologists in 2009. He is an active Clinician and Academic, has posts in both the Hospital and University and currently is running an imaging-based trial at UCH under the auspices of the UCLH Comprehensive Biomedical Research Centre.

Extensive clinical research has confirmed his opinion that there is a need for excellent public engagement to support new projects. To that end, Rowland has been heavily involved with cancer charities – such as Cancer Research UK (www.cancerresearchuk.org), the Pelican Cancer Foundation (www.pelicancancer.org) and the Prostate Cancer Charity (www.prostate-cancer.org.uk) – to raise public awareness of the work undertaken by the UCL collaboration in this field.



UCL:

UCL (University College London) is London’s leading multidisciplinary university, with 8,000 staff and 22,000 students. Over 140 nationalities are represented among UCL students with overseas students making up nearly a third of the student body. We are now ranked seventh in the world by the Times Higher – QS World University Rankings. Our excellence extends across all academic disciplines; from one of Europe’s largest and most productive centres for biomedical science interacting with eleven leading London hospitals, to world-renowned centres for architecture (UCL Bartlett) and fine art (UCL Slade School).

UCL has recently formed a new academic health science partnership, UCL Partners, which supports over 3,500 medical scientists, senior researchers and consultants, with a combined annual turnover of around two billion pounds.

UCL’s Public Engagement Unit was formed in 2008, and is funded by the Higher Education Funding Council for England, The UK Research Councils and the Wellcome Trust under the Beacons for Public Engagement programme. It acts to change UCL culture to put public engagement at the centre of teaching and research, and hosts experimental public projects, with the aim of creating learning that can be shared with the higher education and research sectors.

The Public Engagement Unit has three staff: Dr. Steve Cross, who leads the unit, Dr. Hilary Jackson, who runs the Unit’s funding streams and works with early-career staff, and Gemma Moore, who is the Unit’s Evaluation Officer.


UCL (University College London) is London’s leading multidisciplinary university, with 8,000 staff and 22,000 students. Over 140 nationalities are represented among UCL students with overseas students making up nearly a third of the student body. We are now ranked seventh in the world by the Times Higher – QS World University Rankings. Our excellence extends across all academic disciplines; from one of Europe’s largest and most productive centres for biomedical science interacting with eleven leading London hospitals, to world-renowned centres for architecture (UCL Bartlett) and fine art (UCL Slade School).